SCHEMBL6488013

SCHEMBL6488013

COC(=O)c1c(F)cccc1COc1cc(C)c2nc(C)n(Cc3ccc(-c4ccccc4)cc3Cl)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BDKRB1 P46663 4/20 0.36
DCTPP1 Q9H773 2/20 0.35
PIK3C2B O00750 2/20 0.35
TP53 P04637 3/20 0.35
MAPT P10636 2/20 0.35
ALOX5AP P20292 2/20 0.34
AGTR1 P30556 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
HSP90AA1 P07900 1/20 0.34
HSP90B1 P14625 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6492529 0.93 PIK3C2B (0.38) DCTPP1PIK3C2BTP53MAPTALOX5AP
SCHEMBL6496471 0.93 DCTPP1 (0.37) DCTPP1PIK3C2BTP53MAPTALOX5AP
SCHEMBL6500738 0.93 PIK3C2B (0.38) DCTPP1PIK3C2BTP53ALOX5APAGTR1
SCHEMBL6498346 0.91 CD274 (0.37) DCTPP1PIK3C2BTP53MAPTALOX5AP
SCHEMBL6498787 0.89 BCL2 (0.40) DCTPP1PIK3C2BTP53MAPTALOX5AP
SCHEMBL6499859 0.88 DCTPP1 (0.42) DCTPP1PIK3C2BBCL2MCL1
SCHEMBL6500643 0.87 ALOX5AP (0.40) DCTPP1PIK3C2BALOX5APBCL2MCL1
SCHEMBL6502905 0.87 PIK3C2B (0.41) DCTPP1PIK3C2BALOX5APBCL2MCL1
SCHEMBL6488163 0.85 PIK3C2B (0.37) DCTPP1PIK3C2BTP53MAPTALOX5AP
SCHEMBL6498230 0.85 ALOX5AP (0.38) DCTPP1TP53MAPTALOX5APAGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD BDKRB1 501/4885DCTPP1 1534/4885PIK3C2B 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.